In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.

Copyright Business Wire 2010

If you liked this article you might like

Learn to Love Selloffs

M&A and Dividends Provide Reasons to Dig European Miners

Grain Glut Has Bunge Searching Couch Cushions for Loose Change

Bunge Stock Rises After It Hires JPMorgan and Shearman & Sterling to Defend Against Takeover Bid

Stocks Add to Gains as Fed Supports Balance Sheet Reduction, Rate Hike 'Soon'